title: The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
authors.affiliation: Indiana University School of Medicine, Indianapolis, IN, USA. nchalasa@iupui.edu
authors.forename: Naga
authors.initials: N
authors.lastname: Chalasani
authors.forename: Zobair
authors.initials: Z
authors.lastname: Younossi
authors.forename: Joel E
authors.initials: JE
authors.lastname: Lavine
authors.forename: Anna Mae
authors.initials: AM
authors.lastname: Diehl
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Brunt
authors.forename: Kenneth
authors.initials: K
authors.lastname: Cusi
authors.forename: Michael
authors.initials: M
authors.lastname: Charlton
authors.forename: Arun J
authors.initials: AJ
authors.lastname: Sanyal
mesh_terms: D005234:Fatty Liver / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use; D065626:Non-alcoholic Fatty Liver Disease; D015995:Prevalence; D012307:Risk Factors; D045162:Thiazolidinediones / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D045162:Thiazolidinediones; D014810:Vitamin E; D008687:Metformin